G6PD and neoplasm: Taken together, these studies suggest that targeting the PPP through inhibition of G6PD can represent a “best of both worlds” situation in which tumor cells may not be as metabolically plastic as T cells due to their overreliance on specific metabolites, allowing T cells to leverage the shift in metabolic fuel to their benefit.